Understanding Familial Nasal Acilia and Ciliary Aplasia
At a Glance
Familial nasal acilia is now often understood as reduced generation of motile cilia, an inherited condition in which airway cells make too few cilia to clear mucus. Doctors may repeat tests, assess genes and lungs, and recommend airway-clearance care.
Finding out you have familial nasal acilia or ciliary aplasia can be a confusing experience, largely because these terms are rarely used in modern medicine. You may find very little information online or in medical books. This is because what was once called “acilia” (meaning “no cilia”) is now better understood as a specific part of a broader group of conditions called ciliopathies—specifically a subtype known as Reduced Generation of Multiple Motile Cilia (RGMC) [1][2].
In the past, if a doctor looked at a sample of nasal tissue and saw no cilia, they might have called it “nasal acilia.” Today, specialists recognize that a descriptive finding of “no cilia” in the nose must be investigated to see if it is a system-wide genetic issue affecting how your cells build these microscopic tools [1].
The Biology of Missing Cilia
To understand this condition, it helps to look at how your body’s “cleaning crew” is built. Most cells in your airway are multiciliated cells, meaning they should each have hundreds of tiny, hair-like motile cilia that wave in unison to sweep mucus and germs out of your nose and lungs [1][3].
In RGMC, the “construction phase” of these cilia is broken. The process, called centriole amplification, is where a cell creates the hundreds of tiny “anchors” (centrioles) needed to sprout cilia [4][5].
- The Blueprint Error: Mutations in certain genes, most commonly CCNO or MCIDAS, act like a missing page in the construction manual [6][3].
- The Result: Because the cell can’t make the anchors, it can’t sprout the cilia. Instead of hundreds of cilia, a cell might have only a few, or none at all [2][3].
Is it Different from PCD?
You may hear your condition discussed alongside Primary Ciliary Dyskinesia (PCD). PCD is a heterogeneous umbrella term that includes defects in cilia number and multiciliogenesis, assembly, ultrastructure, beat regulation, and combinations of these. RGMC is a specific reduced-number phenotype within the motile-ciliopathy/PCD spectrum [7].
Normal-looking remaining cilia or a normal structural evaluation does not by itself exclude PCD [2][3]. Because the symptoms (chronic congestion, sinus infections, and lung issues) overlap heavily, RGMC is now generally managed as a subtype of PCD [1][2].
Understanding “Isolated” and “Familial”
The term “familial nasal acilia” suggests the problem is limited only to your nose and runs in your family. However, modern research has found that a finding from one nasal sample does not by itself establish what is happening in your lower airways.
In most cases, if cilia are missing in the nose due to genetics, they are also missing or reduced in the lungs [1]. You may not have noticed lung symptoms yet, but doctors will often look for bronchiectasis (permanent widening and damage of the airways) which can develop over time due to poor mucus clearance [8][3].
“Familial” means the condition is inherited. Most forms of RGMC (like CCNO and MCIDAS) are autosomal recessive, meaning a person must inherit a mutated gene from both parents to have the condition [6][7]. However, other motile-ciliopathy genes can have different inheritance patterns [9][10]. A genetic counselor can guide family testing.
Why Diagnosis is Difficult
It is completely normal to feel frustrated by the lack of clear answers. Diagnosing these conditions is difficult for several reasons:
- Damage vs. Genetics: Infections, smoke, or pollution can temporarily strip away cilia. This is called secondary ciliary dyskinesia. Doctors must repeat tests after you have been healthy to make sure the cilia are truly missing because of your genetics [11][8].
- The “Hidden” Cilia: Because the few cilia that exist in RGMC look normal, standard tests like Transmission Electron Microscopy (TEM) might come back “normal” if the technician happens to look at one of the rare healthy-looking cilia [2].
- Rarity: Because these specific genetic mutations (like CCNO) were only discovered relatively recently, many doctors have never seen a case [3].
Managing the Condition
Since your body’s natural cleaning system is less effective, management focuses on doing the work for your cilia [12].
- Airway Clearance: Techniques to help move mucus out of the sinuses and lungs are the cornerstone of care [7][12].
- Infection Control: Using saline rinses and being proactive with antibiotics when you get sick helps prevent long-term damage [8][13].
- Monitoring Other Systems: While ciliary genes can affect the brain (hydrocephalus) or reproductive system (fertility), this risk is highly gene- and symptom-specific. It is not a routine expectation for every person with RGMC/PCD. A specialist will recommend targeted screening only if warranted [6][3][14].
Common questions in this guide
What does familial nasal acilia mean today?
How is RGMC related to primary ciliary dyskinesia?
What tests can confirm that my cilia are missing?
Can familial nasal acilia affect my lungs?
Is familial nasal acilia inherited, and should relatives be tested?
How is RGMC or familial nasal acilia managed?
Appointments are short. Make every minute count.
Specialist visits move fast. Let us help you prep so your time goes to what matters.
Understanding the condition
Is my nasal acilia considered a form of primary ciliary dyskinesia?
Family and genetics
Could a genetic counselor explain how this condition might be passed down in my family?
Lung monitoring
Would my doctors check my lungs for bronchiectasis?
Get notified when new evidence is published on Familial nasal acilia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (14)
- 1
Live-Imaging Centriole Amplification in Mouse Brain Multiciliated Cells.
Boudjema AR, Al Jord A, Lemaître AI, et al.
Methods in molecular biology (Clifton, N.J.) 2024; (2725()):167-180 doi:10.1007/978-1-0716-3507-0_10.
PMID: 37856024 - 2
Value of transmission electron microscopy for primary ciliary dyskinesia diagnosis in the era of molecular medicine: Genetic defects with normal and non-diagnostic ciliary ultrastructure.
Shapiro AJ, Leigh MW
Ultrastructural pathology 2017; (41(6)):373-385 doi:10.1080/01913123.2017.1362088.
PMID: 28915070 - 3
Systematic Analysis of CCNO Variants in a Defined Population: Implications for Clinical Phenotype and Differential Diagnosis.
Amirav I, Wallmeier J, Loges NT, et al.
Human mutation 2016; (37(4)):396-405 doi:10.1002/humu.22957.
PMID: 26777464 - 4
Mcidas mutant mice reveal a two-step process for the specification and differentiation of multiciliated cells in mammals.
Lu H, Anujan P, Zhou F, et al.
Development (Cambridge, England) 2019; (146(6)) doi:10.1242/dev.172643.
PMID: 30877126 - 5
Deuterosomal cells are the responsible lineage for multiciliogenesis in human airway differentiation.
Yamaki H, Konishi S, Tamai K, et al.
Stem cell reports 2026; (21(4)):102860 doi:10.1016/j.stemcr.2026.102860.
PMID: 41861821 - 6
Bi-allelic mutations in MCIDAS and CCNO cause human infertility associated with abnormal gamete transport.
Ma C, Wu H, Zhu D, et al.
Clinical genetics 2021; (100(6)):731-742 doi:10.1111/cge.14067.
PMID: 34569065 - 7
Diagnosis and management of primary ciliary dyskinesia.
Werner C, Onnebrink JG, Omran H
Cilia 2015; (4(1)):2 doi:10.1186/s13630-014-0011-8.
PMID: 25610612 - 8
Novel CYCLIN-O pathogenic variants in a patient presenting with bronchiectasis secondary to reduced generation of multiple motile cilia.
Yap KH, Lim AYH, Thomas B, et al.
Respirology case reports 2024; (12(11)):e70057 doi:10.1002/rcr2.70057.
PMID: 39479223 - 9
De Novo Mutations in FOXJ1 Result in a Motile Ciliopathy with Hydrocephalus and Randomization of Left/Right Body Asymmetry.
Wallmeier J, Frank D, Shoemark A, et al.
American journal of human genetics 2019; (105(5)):1030-1039 doi:10.1016/j.ajhg.2019.09.022.
PMID: 31630787 - 10
Mutations in CFAP47, a previously reported MMAF causative gene, also contribute to the respiratory defects in patients with PCD.
Ge H, Zhou W, He M, et al.
Molecular genetics & genomic medicine 2024; (12(1)):e2278 doi:10.1002/mgg3.2278.
PMID: 37723893 - 11
Clinical Features and Associated Likelihood of Primary Ciliary Dyskinesia in Children and Adolescents.
Leigh MW, Ferkol TW, Davis SD, et al.
Annals of the American Thoracic Society 2016; (13(8)):1305-13 doi:10.1513/AnnalsATS.201511-748OC.
PMID: 27070726 - 12
Current and Future Treatments in Primary Ciliary Dyskinesia.
Paff T, Omran H, Nielsen KG, Haarman EG
International journal of molecular sciences 2021; (22(18)) doi:10.3390/ijms22189834.
PMID: 34575997 - 13
Pulmonary exacerbations in primary ciliary dyskinesia.
Gatt D, Golan-Tripto I, Goldbart A, Hazan G
European journal of pediatrics 2026; (185(9)).
PMID: 42704391 - 14
Hydrocephalus and diffuse choroid plexus hyperplasia in primary ciliary dyskinesia-related MCIDAS mutation.
Robson EA, Dixon L, Causon L, et al.
Neurology. Genetics 2020; (6(4)):e482 doi:10.1212/NXG.0000000000000482.
PMID: 32802948
This page is for informational purposes only and does not constitute medical advice. It cannot diagnose familial nasal acilia or RGMC; discuss testing and care with your cilia specialist, pulmonologist, ENT clinician, or genetic counselor.